
    
      To 16 healthy subjects, following treatments are administered dosing in each period and
      wash-out period is a minimum of 7 days.

      Reference drug: D744 Test drug: CKD-385 64 mg formulation I Pharmacokinetic blood samples are
      collected up to 48 hrs. The pharmacokinetic characteristics and safety are assessed.
    
  